Table 1.
Epidemiological data of rosacea patients.
Table 2.
Cronbach's alpha for the RosQol (n = 265).
Table 3.
Cronbach’s alpha for individual items of the RosQol (n = 265).
Table 4.
Cronbach's alpha for the adjusted RosQol (n = 265).
Table 5.
Test-retest reliability for the adjusted RosQol (±S, n = 77).
Table 6.
Construct validity for the adjusted RosQol (n = 265).
Table 7.
Construct validity for individual items of the adjusted RosQol (n = 265).
Table 8.
Correlation with the DLQI (n = 251).
Fig 1.
Rosacea: Pre- and post-treatment scores on the adjusted RosQol.
After a four-week treatment course, there was a difference between pre- and post-treatment total and dimensional scores on the adjusted RosQol **p < 0.01.
Fig 2.
Rosacea: The relationship between self-evaluated symptoms and the adjusted RosQol.
There was a positive correlation between the symptom score and adjusted RosQol score (r = 0.44, p < 0.01).
Table 9.
Scores on the adjusted RosQol before and after treatment (±S, n = 117).